Overview
Elisabetta Marangoni practices practicing medicine in Paris, France.
Ms. Marangoni is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, HER-2 Positive Breast Cancer, and Endoscopy.
She is actively involved in clinical research, co-authoring 161 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Elisabetta Marangoni
Is Elisabetta Marangoni a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Elisabetta Marangoni is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Elisabetta Marangoni participate in research or clinical trials?
Yes. Elisabetta Marangoni has published 161 articles and abstracts on conditions like Breast Cancer. You can view a list of Elisabetta Marangoni's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerMs. Marangoni isDistinguished. Learn about Breast Cancer.
- Triple-Negative Breast CancerMs. Marangoni isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Acute Respiratory Distress Syndrome (ARDS)
- HER-2 Positive Breast CancerMs. Marangoni isAdvanced. Learn about HER-2 Positive Breast Cancer.
- PIK3CA-Related Overgrowth SpectrumMs. Marangoni isAdvanced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Experienced
- COVID-19Ms. Marangoni isExperienced. Learn about COVID-19.
- EndoscopyMs. Marangoni isExperienced. Learn about Endoscopy.
- Infantile PneumothoraxMs. Marangoni isExperienced. Learn about Infantile Pneumothorax.
- MelanomaMs. Marangoni isExperienced. Learn about Melanoma.
- NecrosisMs. Marangoni isExperienced. Learn about Necrosis.
- Ovarian CancerMs. Marangoni isExperienced. Learn about Ovarian Cancer.
- RetinoblastomaMs. Marangoni isExperienced. Learn about Retinoblastoma.
- Severe Acute Respiratory Syndrome (SARS)Ms. Marangoni isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Uveal MelanomaMs. Marangoni isExperienced. Learn about Uveal Melanoma.